NYSE
Closed
Oct 9, 2026
Day's Range
27.5952 wk Range
23.62Valuation
Enterprise Value
208.81B
P/E (Trailing)
‪36.18‬
P/E (Forward)
‪9.49‬
PEG Ratio
‪-0.33‬
Price / Sales (TTM)
‪2.46‬
Price / Book
‪1.83‬
EV / EBITDA
‪8.22‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪6.80%‬
Operating Margin
‪27.87%‬
Return on Assets
‪5.78%‬
Return on Equity
‪5.01%‬
Ownership
Shares Outstanding
5.69B
Float
5.69B
Short % of Shares Outstanding
‪2.72%‬
Held by Insiders
‪0.10%‬
Held by Institutions
‪69.16%‬
Price stats
Beta
‪0.27‬
50-Day Avg
‪27.44‬
200-Day Avg
‪26.42‬
Dividends
Payout Ratio
‪226.32%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 28.61‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Compared with companies in Drug Manufacturers - General listed on NYSE.
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
